AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

HARROW, INC. Director's Dealing 2012

Mar 27, 2012

31774_dirs_2012-03-27_edf49134-bbbd-45c3-8173-08991eb81102.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2012-02-28

Reporting Person: Ladonnikov Alexej (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1984156	Direct